However, its predictive power lost strength (P=0.051) after adjustment for covariate confounders, particularly CD38, likely because high expression levels of CD38 and lnc-IRF2-3 define largely overlapping CLL subgroups (Supplementary Figure S3). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.